Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Conatus: Emricasan's 4 Indications Present A Lucrative Opportunity In The Liver Disease Market
Conatus: Emricasan's 4 Indications Present A Lucrative Opportunity In The Liver Disease Market
Conatus: Emricasan's 4 Indications Present A Lucrative Opportunity In The Liver Disease Market
Submitted by
admin
on July 18, 2015 - 10:48am
Source:
Seeking Alpha
News Tags:
Conatus Pharmaceuticals
emricasan
liver disease
NASH
cirrhosis
Headline:
Conatus: Emricasan's 4 Indications Present A Lucrative Opportunity In The Liver Disease Market
Do Not Allow Advertisers to Use My Personal information
